2016 Sep 28
Believe in Brooke: Finding peace with DIPG
A community has rallied around an 8-year-old with pediatric brain cancer, and the doctor who has saved her life so far with his experimental treatment. Read more
2016 Sep 28
Freezing technique is an effective alternative to lumpectomy for early stage breast cancer, study finds
A deep-freezing technique known as cryoablation is a viable alternative to traditional surgery in many early-stage breast cancers, according to Rache Simmons, M.D. Read more
2016 Sep 27
New drugs, immuno-oncology advances gastric cancer treatment paradigm
Immuno-oncology and the classification of subtypes of gastric cancer could greatly advance treatment efficacy and variation, according to Manish A. Shah, M.D. Read more
2016 Sep 26
Collaborative MDS research yields world-class results
The Weill Cornell Medicine Leukemia Program is part of collaborative research into myelodysplastic syndromes (MDS). Read more
2016 Sep 21
We Are Weill Cornell Medicine: Dr. Olivier Elemento
Olivier Elemento, Ph.D., is a featured faculty member in the #WeAreWCM campaign. Read more
2016 Sep 21
Moneyball could offer winning strategy for drug development
Researchers from the lab of Olivier Elemento, Ph.D., have developed a promising new AI tool that better predicts which drug candidates are likely to be too toxic. Read more
2016 Sep 20
Five questions for Harold Varmus
Harold Varmus, M.D., reflects on the state of medical research and the public's understanding of it, as well as politics. Read more
2016 Sep 20
Cancer Care: The Next Generation
Several Meyer Cancer Center faculty are featured in this half-hour television special on cancer. Read more
2016 Sep 19
The impact of Tecentriq to treat patients with advanced bladder cancer
The immunotherapy Tecentriq (atezolizumab) has been found to be non-toxic and has demonstrated a major survival advantage in patients with metastatic urothelial bladder cancer, according to David Nanus, M.D. Read more
2016 Sep 19
The cooperation that causes cancer
Ari Melnick, M.D., has uncovered the mechanisms by which B-cells can transform to cause cancer, and found that it requires a special cooperation between regulatory protein EZH2 and transcription protein BCL6. Read more
2016 Sep 19
The height of dedication
Matthew Bernstein, 16, is contributing to a cure for the cancer that claimed his brothers life. Read more
2016 Sep 16
Chemical tags on RNA silence X chromosome in females
The addition of a chemical tag on an RNA molecule is the critical switch that inactivates one X chromosome in every cell, ensuring healthy development in all female mammals, according to new research by Samie Jaffrey, Ph.D. Read more
2016 Sep 15
Identifying Genetic Changes in Advanced Prostate Cancer: What It Means for Patients
Himisha Beltran, M.D., discusses molecular-based tools used to examine genetic changes in prostate cancer. Read more
2016 Sep 14
Almost all men with early prostate cancer survive 10 years, regardless of treatment
Jim Hu., M.D., weighs in on a pair of studies about survival rates in prostate cancer. Read more
2016 Sep 08
DIPG: A New Beginning
Mark M. Souweidane, M.D., writes about a pivotal point in his career, and for future treatments for children with a rare and deadly form of brain cancer. Read more
2016 Sep 07
What are the long-term health effects of living in space?
Christopher Mason and Francine Garrett-Bakelman are analyzing blood samples as part of a NASA experiment on twin astronauts. Read more
2016 Sep 05
Virtual Vision
Researchers at Weill Cornell Medicine are using virtual reality goggles to bring that fantasy to life—with the aim of improving cancer care. Read more
2016 Sep 05
Small wonders: Cerebral organoids
Howard Fine, M.D., has been successfully growing organoids to study brain cancer in an innovative new way. Read more
2016 Sep 01
Injury risk spikes while cancer patients seek diagnosis
More attention should be paid to the negative influence a cancer diagnosis has on patients' health and well-being, according to Holly Prigerson, Ph.D. Read more
2016 Sep 01
Why we need precision medicine—now
Precision medicine efforts at Weill Cornell Medicine were highlighted in this guest piece in The Hill. Read more
